A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00405743
Recruitment Status : Completed
First Posted : November 30, 2006
Last Update Posted : September 18, 2013
Information provided by (Responsible Party):
Clavis Pharma

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2009
  Actual Study Completion Date : May 2010
  Certification/Extension First Submitted : September 12, 2013